Finished product reference
Acetaminophen / Caffeine
Tablet, Effervescent · Oral · 500 mg/65 mg
- List code
- 53286
- Pharmacologic class
- Central Nervous System Stimulant · Methylxanthine
Indications
Uses temporarily relieves minor aches and pains due to: headache muscular aches
Dosage and administration (summary)
Directions do not use more than directed adults and children 12 years and over; take 2 caplets every 6 hours; not more than 6 caplets in 24 hours children under 12 years: ask a doctor
Warnings and precautions
Warnings Liver Warning: This product contains acataminophen. Severe liver damage may occure if you take. more than 6 caplets in 24 hours, whihc is the maximum daily amount. with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include: skin reddening blisters rash If a skin reaction occurs, stop use and seek medical help right away. Caffeine warning: The recommended dose of this product contains about as much caffeine as a cup of coffee.
Storage and supply
Other information store at 20°-25°C (68°-77°F) close cap tightly after use read all product information before using. Keep this box for important information.
Source: Acetaminophen And Caffeine (Tension Headache Relief) — US FDA prescribing information, 2026-01-16, DailyMed. Summarised and shortened; the full label governs. Iranian registration, indications and labelling may differ.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.